Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein

被引:405
|
作者
Harper, JD
Lieber, CM
Lansbury, PT
机构
[1] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
[2] MIT, Dept Chem, Cambridge, MA 02139 USA
[3] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源
CHEMISTRY & BIOLOGY | 1997年 / 4卷 / 12期
关键词
Alzheimer's disease; amyloid; atomic force microscopy; nucleation; protofibril seeding;
D O I
10.1016/S1074-5521(97)90303-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Amyloid plaques composed of the fibrillar form of the amyloid-beta protein (A beta) are the defining neuropathological feature of Alzheimer's disease (AD). A detailed understanding of the time course of amyloid formation could define steps in disease progression and provide targets for therapeutic intervention. Amyloid fibrils, indistinguishable from those derived from an AD brain, can be produced in vitro using a seeded polymerization mechanism. In its simplest form, this mechanism involves a cooperative transition from monomeric A beta to the amyloid fibril without the buildup of intermediates. Recently, however, a transient species, the A beta amyloid protofibril, has been identified. Here, we report studies of A beta amyloid protofibril and its seeded transition into amyloid fibrils using atomic force microscopy. Results: Seeding of the protofibril-to-fibril transition was observed. Preformed fibrils, but not protofibrils, effectively seeded this transition. The assembly state of A beta influenced the rate of seeded growth, indicating that protofibrils are fibril assembly precursors, The handedness of the helical surface morphology of fibrils depended on the chirality of A beta, Finally, branched and partially wound fibrils were observed. Conclusions: The temporal evolution of morphologies suggests that the protofibril-to-fibril transition is nucleation-dependent and that protofibril winding is involved in that transition. Fibril unwinding and branching may be essential for the post-nucleation growth process. The protofibrillar assembly intermediate is a potential target for AD therapeutics aimed at inhibiting amyloid formation and AD diagnostics aimed at detecting presymptomatic disease.
引用
收藏
页码:951 / 959
页数:9
相关论文
共 50 条
  • [41] Coexisting order and disorder within a common 40-residue amyloid-β fibril structure in Alzheimer's disease brain tissue
    Ghosh, Ujjayini
    Yau, Wai-Ming
    Tycko, Robert
    CHEMICAL COMMUNICATIONS, 2018, 54 (40) : 5070 - 5073
  • [42] Inhibition of amyloid fibril formation via naturally occuring phenolic compounds monitored by atomic force microscopy
    Pollock, Casey
    Dasani, Divya
    Nghiem, Tyler
    Vitale, Rebecca
    Moriarty, Daniel
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [43] Clusterin promotes amyloid plaque formation in a mouse model of Alzheimer's disease: Dissociation between fibril formation and neuritic toxicity
    Holtzman, D
    O'dell, M
    Kierson, M
    DeMattos, R
    Harmony, J
    Bales, K
    Paul, S
    Lilly, E
    Aronow, B
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S235 - S235
  • [44] Biophysical Properties of the Fibril Structure of the Toxic Conformer of Amyloid-β42: Characterization by Atomic Force Microscopy in Liquid and Molecular Docking
    Biyani, Radhika
    Hirata, Kaito
    Oqmhula, Kenji
    Yurtsever, Ayhan
    Hongo, Kenta
    Maezono, Ryo
    Takagi, Masahiro
    Fukuma, Takeshi
    Biyani, Manish
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (23) : 27789 - 27800
  • [45] A new therapeutic approach to Alzheimer's disease - Inhibiting the aggregation and fibril formation of Aβ
    Gu, Feng
    Luo, Huan-Min
    Chinese Pharmaceutical Journal, 2004, 39 (12) : 887 - 890
  • [46] Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease
    Yang Lei
    Zhou Renyuan
    ENDOCRINOLOGY, 2018, 159 (12) : 3885 - 3894
  • [47] Bifunctional cysteine gold nanoclusters for β-amyloid fibril inhibition and fluorescence imaging: a distinctive approach to manage Alzheimer's disease
    Resmi, A. N.
    Rekha, C. R.
    Dhushyandhun, M. E.
    Elangovan, Sarathkumar
    Shenoy, Sachin J.
    Gulia, Kamalesh K.
    Jayasree, Ramapurath S.
    JOURNAL OF MATERIALS CHEMISTRY B, 2023, 11 (21) : 4715 - 4724
  • [48] Phenolic Oxime Oligomers Inhibit Alzheimer's Amyloid Fibril Formation and Disaggregate Fibrils In Vitro
    Dolphin, Gunnar T.
    Renaudet, Olivier
    Ouberai, Myriam
    Dumy, Pascal
    Garcia, Julian
    Reymond, Jean-Louis
    CHEMBIOCHEM, 2009, 10 (08) : 1325 - 1329
  • [49] Unique Molecular Signatures of Alzheimer's Disease Amyloid β Peptide Mutations and Deletion During Aggregate/Oligomer/Fibril Formation
    Poduslo, Joseph F.
    Howell, Kyle G.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (03) : 410 - 423
  • [50] CYSTATIN C BINDS AMYLOID β AND INHIBITS ITS OLIGOMERIZATION, FIBRIL FORMATION, AND DEPOSITION IN ALZHEIMER'S DISEASE MOUSE MODELS
    Levy, Efrat
    NEUROPEPTIDES, 2009, 43 (02) : 149 - 150